Antiretroviral medicines work against different stages of the HIV life cycle. Researchers investigate existing drug classes and explore new approaches to address treatment challenges, including drug resistance, safety, and medication delivery.
Laboratory research supports the early stages of antiviral drug development by providing scientific evidence about how potential medicines work. Researchers use biochemical tests, cell-based experiments, and other validated laboratory methods to study drug activity and investigate possible effects on viral replication.
Drug discovery is followed by preclinical research and clinical development, where candidate medicines undergo additional evaluation. Laboratory findings alone do not establish that a compound is safe or effective for human treatment.
The World Health Organization supports laboratory networks that conduct quality-assured HIV drug resistance testing. These networks help generate reliable information about resistance patterns and support treatment-related research and monitoring.
HIV can develop genetic mutations during replication, and some mutations may reduce the effectiveness of particular antiviral medicines. Drug resistance research helps scientists understand these changes and investigate ways to maintain effective treatment.
Researchers examine resistance-associated mutations, medication effectiveness, and laboratory testing methods. Viral load monitoring and resistance testing can provide information for assessing treatment response and supporting clinical decisions.
HIV antiviral drug discovery and laboratory research contribute to the development and improvement of HIV medicines. Scientific studies examine viral targets, potential drug compounds, laboratory testing methods, and resistance mechanisms. Continued research helps expand understanding of HIV biology and supports the development of treatment approaches. Laboratory findings, preclinical studies, and clinical research each play distinct roles in evaluating antiviral medicines and their potential applications.